EuroBiOpartnering - the EuroBiO 2008 Business Convention

EuroBiO 2008, the Life Sciences Event of the EU Presidency awarded prestigious EU Presidency Label, will take place at the Palais des Congrès conference centre in Paris from Tuesday, October 7th to Thursday, October 9th inclusive. During these three days, the international life science community will be brought together around the Four Pillars that made the success of BIO in the US: the Conference Pillar, the Business Convention Pillar, the Exhibition Pillar, and the Career Fair Pillar.

EuroBiOpartnering will be taking place during the three days of EuroBiO. This international business convention is designed for start-ups and other small & medium-sized businesses as well as multinationals from the biotech, pharmaceutical, diagnostics, agrifood and environmental sectors, as well as investors and banks, private and public-sector research organizations or public institutions and local authorities.

Its objectives are to enable participants to contact and forge links with their future partners, obtain finance, and identify innovative projects. It also aims at boosting interest from international investors in biotechnology companies based in the Paris Region and throughout France and at encouraging new entities to relocate here.

A web portal (EuroBiOpartnering) is entirely dedicated to the business convention. It allows the participants, before the start of EuroBiO 2008, to introduce their companies and present their offers and requests, to identify the profiles which match their requirements, and to plan one-to-one interviews and meetings, which will take place at the EuroBiO. The website gives access to the three types of partnerting:

  • Business-to-Business;
  • Business-to-Technology;
  • Research Funds-to-Business.

Business‐to‐business
Business-to-business partnering is the core strand of EuroBiO 2008 and brings together European, US and Asian companies. The B to B facilitates contact between future commercial collaborators, or development partners.

Business‐to‐Technology
Registration enables companies to find institutions and technology transfer organisations with a huge range of projects for licensing, acquisition, or collaboration.

Research Funds-to-Business
Awarded EU label and starting with the EU's massive Framework 7 Program sympathetic to the administrative needs of small-to-medium-sized businesses, EuroBiO offers a direct connection to R&D funding at a European and national level. Registration enables companies to identify projects in preclinical development, orphan diseases, neurobiology they wish to lead or participate in.

For further information, please visit:
http://www.eurobio2008.com

Related news articles:

About EuroBiO
Founded in 1997 on the initiative of the French Ministry of Research, the then called European Biotech Crossroads has rapidly succeeded in bringing together all the biotechnology actors and stakeholders: life science companies, start‐up projects, students, researchers, private & public‐sector research organizations, industry bodies, investors, consulting firms, multinationals from the biotech, pharmaceutical, diagnostics, agrifood & environmental sectors, local authorities, clusters, bioparks, bioincubators, public authorities and regulatory bodies.

In 2006, the European Biotech Crossroads took place in Paris for its 10th anniversary. Under the guidance of Eric Poincelet, former Director General of The World Life Sciences Forum BioVision and founder of BioSquare, the Event was totally transformed on this occasion and remodelled according to the US BIO structure: Four Pillars, Three Sectors, and Three Generations. To reflect this transformation into what is set to become "The European BIO", the name EuroBiO was adopted. Over 4,000 experts already joined in the newly "revamped" EuroBiO in 2006. And over 5,000 are expected for this EU Presidency Edition 2008.

EuroBiO is now a truly international event, with a prime focus on European issues. The Event is dedicated to Life Sciences in general - and in particular, to biotech's three major fields of application - Health, Environment and Agro‐industry.

The overall setting of EuroBiO 2008 was awarded to Paris and Region Ile‐de‐France; the concrete organization of the event is ensured by its Regional Economic Development Agency for Paris Ile-de-France (ARD) and its Partner, Package Organization.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Computer Models Open Door to Far Mor…

With antibiotic resistance a growing problem, University of Virginia School of Medicine researchers have developed cutting-edge computer models that could give the disease-fighting drugs a laser-like precision to target only...

New Biomarkers to Detect Colorectal Canc…

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential for colorectal cancer. In a...

Sam Neville Joins the Highland Marketing…

Leading chief nursing information officer Sam Neville is joining the Highland Marketing advisory board. Sam brings a passion for nursing and safety to the board, which debates the big issues...

AI Model Identifies Potential Risk Genes…

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can...

AI Tool that may Assist Underserved Hosp…

As the fields of healthcare and technology increasingly evolve and intersect, researchers are collaborating on the best ways to use emerging technologies such as artificial intelligence (AI) to care for...